US Stock MarketDetailed Quotes

SYRE Spyre Therapeutics

Watchlist
  • 25.790
  • +0.360+1.42%
Close Jun 18 16:00 ET
1.31BMarket Cap-567P/E (TTM)

Spyre Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Spyre Therapeutics Earnings Date

Currency: USD

Period

Q1 FY2024 Earnings

--

Revenue(YoY)

0.00

-100.00%
EPS(YoY)

-1.20

+75.46%
Analyst Rating

Strong Buy

Jun 13, 2024

Spyre Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 7 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 0.000--
--2024/Q2-- / 2.857M--
--2024/Q10.000 / 0.000--
--2023/Q40.000 / 220.000K--
--2023/Q30.000 / 0.000--
--2023/Q2688.000K / 0.000--
--2023/Q1198.000K / 84.000K--
--2022/Q4168.000K / 58.000K--
--2022/Q3174.000K / 208.330K--
--2022/Q2625.000K / 709.500K--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 0.000--
--2024/Q2-- / 2.857M--
--2024/Q10.000 / 0.000--
--2023/Q40.000 / 220.000K--
--2023/Q30.000 / 0.000--
--2023/Q2688.000K / 0.000--
--2023/Q1198.000K / 84.000K--
--2022/Q4168.000K / 58.000K--
--2022/Q3174.000K / 208.330K--
--2022/Q2625.000K / 709.500K--

Unlock Free Earnings Estimates

Spyre Therapeutics Earnings Reports

  • Spyre Therapeutics | 10-Q: Quarterly report

    May 9 16:16 ET

  • Spyre Therapeutics | 10-K/A: Annual report (Amendment)

    Mar 1 06:19 ET

  • Spyre Therapeutics | 10-K: Annual report

    Feb 29 09:04 ET

  • Aeglea BioTherapeutics: Q3 2023 Earnings Report

    Nov 9, 2023 16:10 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Jun 13, 2024

    Strong Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    %Chg